DBV Technologies (DBVT)
$3.57 -$0.47 (-12.35%) 10:23 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$74.90M -
Day's Range
$3.34 - $3.59 -
Volume
506,219 -
52 Week Low / High
$2.20 - $10.70 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
DBVT's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 0
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $5.13
- Target Price
Company News
-
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF — Jan 16th, 2024
DBV Technologies S.A. AMF Regulated Information Montrouge, France, January 16, 2024 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical compan...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$